Kenneth Baker, Ph.D. is Associate Staff in the Department of Neurosciences at the Lerner Research Institute. He is co-director of the Center of Excellence in Translational Therapies for Post-Stroke Rehabilitation at the Cleveland Clinic. Dr. Baker earned his Ph.D. at the University of Arizona, followed by a fellowship in Movement Disorders Research in the Department of Neurology at the Cleveland Clinic. He has over twenty years of experience in deep brain stimulation, both clinically and in the laboratory involving the therapeutic application and mechanisms of neurostimulation-based approaches to neurologic and psychiatric disease.

Eva Bartels, neurology residency in Hamburg and Munich. In summer 1993 visiting professor in WFU, Winston-Salem, NC, USA. 2000-2007 head of the Neurovascular Laboratory at the University in Göttingen, where she became 2006 professor of neurology. Since 2008 professor of neurology at the Technical University in Munich. Additionally, she works in her neurological practice, Center for Neurological Vascular Diagnostics in Munich. Her main research interests are cerebrovascular disease and neurosonology. She pioneered in the color-coded duplex ultrasonography of the vertebral arteries and the intracranial vessels. In 1992, the Young Investigators Award in New Orleans for these topics. From 2001-2003 she was chair of the Neurosonology Section of the American Institute of Ultrasound in Medicine (AIUM). From 1997-2007 she was treasurer of the European Society of Neurosonology and Cerebral Hemodynamics (ESNCH), since 2007 she is educational coordinator and since 2022 chair of the International Certification Committee for Neurosonology. She hosted the 1st meeting of the ESNCH in Munich in 1997 as secretary, and in 2011, the 16th meeting of the ESNCH as congress president. Her textbook “Color-Coded Duplex Ultrasonography of the Cerebral Vessels”, 1999, became a fundamental work for neurosonology. In 2018 the second edition was published (Schattauer /Thieme). In 2012 she edited the book “New Trends in Neurosonology and Cerebral Hemodynamics” which is free under http://www.sciencedirect.com/science/journal/2211968X/1

Philip Bath (FRCP DSc FMedSci) is Stroke Association Professor of Stroke Medicine and Head of Academic Stroke at the University of Nottingham, an Emeritus NIHR Senior Investigator, and consultant stroke physician at Nottingham University Hospitals NHS Trust. He was the UK Stroke Association’s Keynote Lecturer in 2015, the International Stroke Conference William M Feinberg Award Lecturer for Excellence in Clinical Stroke in 2016 and received the President’s Award for Research from the British Association of Stroke Physicians in 2019 and President’s Award from the World Stroke Organisation in 2021. Prof. Bath’s is a clinical trialist with research interests in acute blood pressure management and antiplatelet and anticoagulant therapy, treatment of post-stroke dysphagia, and prevention of cognitive decline and vascular dementia. He has >500 publications. He was Chief Investigator of the TAIST (Lancet 2001), ENOS (Lancet 2015), TARDIS (Lancet 2018) and RIGHT-2 (Lancet 2019) multicentre phase III randomised controlled trials and leads the ongoing PhEAST trial in post-stroke dysphagia. He coordinates international collaborations on acute stroke blood pressure management; and optimising the design and analysis of trials in acute stroke, stroke prevention, and cognition.